Toggle navigation
Home
Search
Services
Blog
Contact
About
Production and Testing of a Modified Vaccinia Ankara (MVA) Vaccine
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Advanced imaging for diabetic retinopathy
Recep. Protein Tyrosine Phosphatase-k Regulation of EGFR
The role of GCN2-kinase in antigen presenting cell function and tolerance to self
Ultrasound Tissue Erosion for Cardiac Applications
Tpa Activity and Cerebellar Motor Learning
Recently added grants:
Protein Sumoylation in OOCYTE Development
Simulation to Improve Infection Prevention and Patient Safety: The SIPPS Trial
Subtle Motor Functioning and Functional Connectivity in Youth Medically Cleared after Mild TBI
Spatiotemporal interrogation of molecular mechanobiololgy at the cell-cell interface with nanotechnology tools
Bioactive adhesive material for early vaginal wall detachment in pelvic organ prolapse
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research and Development Contracts (N01)
Project #
N01AI40072-5-0-1
Application #
7580019
Study Section
Project Start
2004-09-30
Project End
2010-03-31
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 AI
Production and Testing of a Modified Vaccinia Ankara (MVA) Vaccine
/ Bavarian Nordic A/S
$4,850,824
NIH 2007
N01 AI
Chaplin, Paul /
NIH 2007
N01 AI
Production and Testing of a Modified Vaccinia Ankara (MVA) Vaccine
/
Comments
Be the first to comment on this grant